ATCC 27217

ATCC 27217 金黄色葡萄球菌

ATCC® Number:	27217™	Price:	$205.00
Organism: Staphylococcus aureus subsp. aureus Rosenbach Designations: 502A Isolation: Nares of nurse Depositor: HR Shinefield Biosafety Level: 2 Shipped: freeze-dried Growth Conditions: ATCC medium3: Nutrient agar or nutrient broth Temperature: 37.0°C Permits/Forms: In addition to the MTA mentioned above, other ATCC and/or regulatory permits may be required for the transfer of this ATCC material. Anyone purchasing ATCC material is ultimately responsible for obtaining the permits. Please click here for information regarding the specific requirements for shipment to your location. Comments: Bacterial interference in treating staphylococcal disease in newborn babies and patients with chronic furunculosis [23701] [23703] [10366] [10433] [23704] [10432] [10434] [10436] [10951] [10435] [23702] Coagulase positive penicillin sensitive does not produce penicillinase usually lysed by phages 7, 47, 53, 54 and 77 serologic type (b)c1 resistant to 5 mcg but sensitive to 10 mcg of tetracycline [10432] References: 10366: Strauss WG, et al. Bacterial interference treatment of recurrent furunculosis. 2. Demonstration of the relationship of strain to pathogeneicity. JAMA 208: 861-863, 1969. PubMed: 5818591 10432: Shinefield HR, et al. Bacterial interference: its effect on nursery-acquired infection with Staphylococcus aureus. I. Preliminary observations on artificial colonzation of newborns. Am. J. Dis. Child. 105: 646-654, 1963. PubMed: 13977323 10433: Boris M, et al. Bacterial interference; protection of  against nasal Staphylococcus aureus infection after colonization with a heterologous S. aureus strain. Am. J. Dis. Child. 108: 252-261, 1964. PubMed: 14168062